| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.25 | 2e-08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.3 | 3e-08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |